187 related articles for article (PubMed ID: 8201592)
1. [L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity.
Haaseth RC; Horan PJ; Bilsky EJ; Davis P; Zalewska T; Slaninova J; Yamamura HI; Weber SJ; Davis TP; Porreca F
J Med Chem; 1994 May; 37(11):1572-7. PubMed ID: 8201592
[TBL] [Abstract][Full Text] [Related]
2. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
[TBL] [Abstract][Full Text] [Related]
3. Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.
Haaseth RC; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
Int J Pept Protein Res; 1990 Aug; 36(2):139-46. PubMed ID: 2177042
[TBL] [Abstract][Full Text] [Related]
4. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
Toth G; Russell KC; Landis G; Kramer TH; Fang L; Knapp R; Davis P; Burks TF; Yamamura HI; Hruby VJ
J Med Chem; 1992 Jun; 35(13):2384-91. PubMed ID: 1320122
[TBL] [Abstract][Full Text] [Related]
5. [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors.
Toth G; Kramer TH; Knapp R; Lui G; Davis P; Burks TF; Yamamura HI; Hruby VJ
J Med Chem; 1990 Jan; 33(1):249-53. PubMed ID: 2153205
[TBL] [Abstract][Full Text] [Related]
6. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
[TBL] [Abstract][Full Text] [Related]
7. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
Lupica CR; Proctor WR; Dunwiddie TV
Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
10. Studies in vitro with ICI 174,864, [D-Pen2, D-Pen5]-enkephalin (DPDPE) and [D-Ala2, NMePhe4, Gly-ol]-enkephalin (DAGO).
Hirning LD; Mosberg HI; Hurst R; Hruby VJ; Burks TF; Porreca F
Neuropeptides; 1985 Feb; 5(4-6):383-6. PubMed ID: 2987739
[TBL] [Abstract][Full Text] [Related]
11. Para-substituted phenylalanine-4 analogues of [L-Ala3]DPDPE: highly selective delta opioid receptor ligands.
Haaseth RC; Zalewska T; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Pept Res; 1997 Sep; 50(3):171-7. PubMed ID: 9309580
[TBL] [Abstract][Full Text] [Related]
12. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors.
Zhao GM; Bhargava HN
Brain Res; 1997 Jan; 745(1-2):243-7. PubMed ID: 9037415
[TBL] [Abstract][Full Text] [Related]
13. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
[TBL] [Abstract][Full Text] [Related]
14. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
Suarez-Roca H; Maixner W
Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
[TBL] [Abstract][Full Text] [Related]
15. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
16. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
17. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions.
Chandrakumar NS; Stapelfeld A; Beardsley PM; Lopez OT; Drury B; Anthony E; Savage MA; Williamson LN; Reichman M
J Med Chem; 1992 Aug; 35(16):2928-38. PubMed ID: 1323677
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.
Misicka A; Lipkowski AW; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
Life Sci; 1997; 60(15):1263-9. PubMed ID: 9096243
[TBL] [Abstract][Full Text] [Related]
19. Enkephalin analogs containing 4,4-difluoro-2-aminobutyric acid: synthesis and fluorine effect on the biological activity.
Winkler D; Sewald N; Burger K; Chung NN; Schiller PW
J Pept Sci; 1998 Dec; 4(8):496-501. PubMed ID: 9927256
[TBL] [Abstract][Full Text] [Related]
20. Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin.
Hansen DW; Stapelfeld A; Savage MA; Reichman M; Hammond DL; Haaseth RC; Mosberg HI
J Med Chem; 1992 Feb; 35(4):684-7. PubMed ID: 1311764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
